Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD4 | P21917 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.38 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.38 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30972121 | 0.93 | ALDH1A1 (0.43) | DRD4LTA4HHRH3L3MBTL1ALDH1A1 | |
| SCHEMBL30971911 | 0.93 | EGFR (0.47) | DRD4SIGMAR1EGFRERBB2HRH3 | |
| SCHEMBL30972116 | 0.85 | SIGMAR1 (0.41) | DRD4SIGMAR1HRH3L3MBTL1ALDH1A1 | |
| SCHEMBL30972091 | 0.82 | HRH3 (0.47) | SIGMAR1HRH3L3MBTL1KMT2A | |
| SCHEMBL30972054 | 0.78 | HRH4 (0.51) | SIGMAR1EGFRERBB2LTA4HHRH3 | |
| SCHEMBL28265317 | 0.78 | SIGMAR1 (0.55) | DRD4SIGMAR1EGFRERBB2HRH3 | |
| SCHEMBL30972154 | 0.77 | LTA4H (0.54) | LTA4H | |
| SCHEMBL30972142 | 0.76 | LTA4H (0.52) | LTA4HHRH3 | |
| SCHEMBL30972139 | 0.74 | HRH3 (0.47) | LTA4HHRH3PRMT5WDR77HRH4 | |
| SCHEMBL30972035 | 0.73 | PRMT5 (0.37) | HRH3KMT2APRMT5WDR77HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240207263-A1 | SELECTIVE MODULATORS OF ATAXIA TELANGIECTASIA MUTATED (ATM) KINASE AND USES THEREOF | SUZHOU ZANRONG PHARMA LIMITED (CN) | 2024-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240207263-A1 | SELECTIVE MODULATORS OF ATAXIA TELANGIECTASIA MUTATED (ATM) KINASE AND USES THEREOF | ATM, CHEK2, CHEK1 | DRD4 4867/4885SIGMAR1 4843/4885EGFR 907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.